Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus

NCT02265744 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

730

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus

Interventions

DRUG: BMS-931699
DRUG: Placebo matching BMS-931699

Sponsor

Bristol-Myers Squibb